Loading...

MREO MEREO BIOPHARMA GROUP PLC Management Changes 8-K Filing

MR B

MR

MEREO BIOPHARMA GROUP PLC

(MREO)

2026 8-K

Director Resignation

Financial Results Announced

Delisting Notification

Clinical Study Results

Q3 Financial Results

Product Expansion

Financial Statements

Financial Results

Clinical Update

License Agreement Update

Q2 Financial Results

Underwriting Agreement

Interim Data from Phase 2/3...

Financial Results Announcement

Extension Agreement with Ru...

Financial Results Announcement

External Links:

On March 26, 2026, Dr. Annalisa Jenkins announced she will not seek re-election as a Director at Mereo BioPharma's upcoming AGM on May 14, 2026; her decision is not due to any disagreements. This event is categorized under 'Changes in management or control' and is considered significant for the company.

AI Assistant

MEREO BIOPHARMA GROUP PLC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.